Policy | July 26, 2022
Funds for R&D in drug discovery and manufacturing :PIB
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Younger Indians have a 10 times higher rate of heart attack
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Subscribe To Our Newsletter & Stay Updated
